🇺🇸 FDA
Pipeline program

Carboplatin

CTU-14005

Phase 2 small_molecule terminated

Quick answer

Carboplatin for Prostatic Neoplasm is a Phase 2 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Prostatic Neoplasm
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials